Stock Report

All about this stock under one free report Last Updated: 27-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Biofrontera AG - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$1.94

up-down-arrow $-0.11 (-5.37%)

As on 06-May-2022 09:30EDT

Market cap

info icon

$76 Mln

Revenue (TTM)

info icon

$28 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

4.6

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -29.36 14.13 -15.27 13.30 44.88
EBIT -60.79 22.03 -79.40 -1.38 -6.93
Net Profit -43.48 -4.26 -9.43 -6.27 -30.82
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-20Dec-19
EBIT-Margin info -40.68-87.74-47.33-31.69-7.52
Net Margin info -33.26-93.25-59.75---24.45
Return on equity info -99.45-157.91-80.54-150.29-58.10
Return on Capital info -34.41-57.56---40.36-24.17
Return on Assets info -22.83-41.10-20.20-22.70-15.68
Debt to Equity (x) info ----0.133.242.34

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
--
-40.36
-24.17
-38.69
-90.41
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-80.54

Lower than Peers by 54.23

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
-80.54
-150.29
-58.10
-89.96
-167.53
Peer Median
-26.31
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-20.20

Lower than Peers by 7.24

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
-20.20
-22.70
-15.68
-30.10
-73.65
Peer Median
-12.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-47.33

Higher than Peers by 12.37

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
-47.33
-31.69
-7.52
-82.84
-124.48
Peer Median
-59.70
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-59.75

Higher than Peers by 11.31

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
-59.75
-42.92
-24.45
-42.06
-133.90
Peer Median
-71.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-15.27

Lower than Peers by 35.83

Year on year growth in net sales

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
-15.27
-0.03
0.48
0.76
0.96
Peer Median
20.56
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-79.40

Lower than Peers by 94.60

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
-79.40
-308.89
86.55
-16.81
-27.08
Peer Median
15.20
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-9.43

Lower than Peers by 17.29

Year on year growth in profit after tax

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
-9.43
-70.37
13.90
44.86
-52.20
Peer Median
7.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.13

--

Total debt / Net worth

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
0.13
3.24
2.34
0.83
3.70
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

1.42

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
1.42
0.15
0.12
0.01
0.05
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.26

Lower than Peers by 2.22

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
1.26
3.15
1.94
3.55
4.49
Peer Median
3.48
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.13

Lower than Peers by 2.16

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
1.13
2.59
1.59
3.14
3.58
Peer Median
3.29
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-3.51

Lower than Peers by 2.54

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
-3.51
--
--
--
--
Peer Median
-0.97
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

10.06

Lower than Peers by 14.27

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
10.06
11.55
16.10
16.35
13.41
Peer Median
24.33
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.34

Higher than Peers by 0.11

Sales / Average Total Assets

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
0.34
0.53
0.64
0.72
0.55
Peer Median
0.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
--
51.40
49.56
43.81
49.66
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
--
451.29
271.30
283.52
785.80
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
--
300.54
224.84
118.58
338.31
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
--
202.16
96.01
208.75
497.15
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Book Value

4.62

Lower than Peers by 0.19

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
4.62
--
--
--
--
Peer Median
4.82
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

139.28

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
139.28
-1.59
13.84
0.40
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

76

Lower than Peers by 8

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Biofrontera AG - ADR
76
--
--
--
--
Peer Median
84
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...